Oral proteases: a new approach to managing coeliac disease.
Gut 2007;56;157-160. doi:10.1136/gut.2005.090498
Anti-tissue transglutaminase antibodies in the follow-up of adult celiac disease.
Aliment Pharmacol Ther. 2009 Aug;30(3):236-44.
Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool
BMJ 2007; 334(7596):729. – doi:10.1136/bmj.39133.668681.BE
Celiac disease: pathogenesis of a model immunogenetic disease.
J Clin Invest 2007; 117(1):41-9. – doi:10.1172/JCI30253
Structural basis for HLA- DQ2-mediated presentation of gluten epitopes in celiac disease.
Proc Natl Acad Sci U S A 2004; 101(12):4175-9. – doi:10.1073/pnas.0306885101
Diagnostic accuracy of coeliac serological tests: a prospective study.
Eur J Gastroenterol Hepatol 2006; 18(5):493-501.
Emerging new clinical patterns in the presentation of celiac disease.
Arch Pediatr Adolesc Med 2008; 162(2):164-8.
Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease.
Clin Chem. 2004;50:2370-5. – doi 10.1373/clinchem.2004.036111
For the ESPGHAN Working Group on Coeliac Disease Diagnosis, on behalf of the ESPGHAN Gastroenterology Committee.European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease.
J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136-60
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency.
Ann N Y Acad Sci 2007; 1109:212-20. doi:10.1196/annals.1398.025
Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays.
Clin Chim Acta 2007; 382(1-2):95-9. – doi:10.1016/j.cca.2007.03.028